FTC Challenges Medical Device Coatings Deal

FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
The US Federal Trade Commission (FTC) has sued to block GTCR’s proposed $627m merger-acquisition of critical medical device coatings manufacturer Surmodics over anticompetition concerns.
FTC sues to block medical device coatings deal
The Federal Trade Commission under President Trump is making its first move to challenge private equity in health care, by suing to block the $627 million acquisition of a maker of specialized coatings for catheters and other medical devices.
FTC Sues GTCR, Surmodics Over Medical Device Coatings Deal (1)
The Federal Trade Commission sued Thursday to block private equity firm GTCR BC Holdings’ acquisition of Surmodics Inc., alleging the deal will lead to further concentration in the market for coatings used by medical device manufacturers.
Surmodics says it will defend proposed acquisition by GTCR against FTC lawsuit
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device coatings, is anticompetitive.” The acquisition of Surmodics by GTCR for $627 million was announced in May.
FTC challenges private equity firm’s acquisition of Surmodics
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics (Nasdaq:SRDX) by GTCR.
FTC Sues to Block Private Equity Firm's Deal to Buy Medical Device Coatings Maker Surmodics
WASHINGTON (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' acquisition by private equity firm GTCR, with the regulatory agency alleging the deal was anticompetitive.
FTC sues to block GTCR’s $627M Surmodics acquisition
The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.
US FTC sues to block private equity purchase of medical company
The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' acquisition by private equity firm GTCR, saying the deal would contribute to high healthcare costs.
FTC sues to block acquisition of Surmodics
The Federal Trade Commission announced it has sued to block GTCR BC Holdings’ acquisition of Surmodics (SRDX), alleging that the deal, which
Surmodics drops after FTC files suit to block its planned sale to GTCR
Surmodics (NASDAQ:SRDX) fell 4.6% after the Federal Trade Commission filed a lawsuit to block its planned $627 million sale to private equity firm GTCR. The FTC filed suit in the U.S. District Court for the Northern District of Illinois,
MyChesCo on MSN7h
FTC Fights to Block Merger Threatening Healthcare Innovation and Patient-Critical Devices
The Federal Trade Commission (FTC) has filed a lawsuit seeking to block GTCR BC Holdings, LLC’s (GTCR) proposed acquisition ...
Crain's Chicago Business2d
FTC targets GTCR in agency's first merger challenge under new Trump term
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
MedTech Dive2d
FTC challenges $627M private equity takeover of Surmodics
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate ...
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, ...
Crain's Chicago Business2d
FTC gives Arthur J. Gallagher's $13.5B AssuredPartners deal closer look
The Rolling Meadows-based insurance broker is pushing back its forecast for when the transaction might close as the ...
Zacks Investment Research on MSN2d
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge
Surmodics, Inc. SRDX recently provided a statement in response to the U.S. Federal Trade Commission (“FTC”) blocking the ...